The effect of trastuzumab on cardiac function in patients with HER2‐positive metastatic breast cancer and reduced baseline left ventricular ejection fraction

We investigated the effect of trastuzumab on cardiac function in a real‐world historic cohort of patients with HER2‐positive metastatic breast cancer (MBC) with reduced baseline left ventricular ejection fraction (LVEF). Thirty‐seven patients with HER2‐positive MBC and baseline LVEF of 40% to 49% we...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouwer, Nathalie I., Steenbruggen, Tessa G., Rier, Hánah N., Kitzen, Jos J. E. M., Smorenburg, Carolien H., van Bekkum, Marlies L., de Jong, Paul C., Drooger, Jan C., Holterhues, Cynthia, Kofflard, Marcel J. M., Boersma, Eric, Sonke, Gabe S., Levin, Mark‐David, Jager, Agnes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
CANCER THERAPY AND PREVENTION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320802/
https://www.ncbi.nlm.nih.gov/pubmed/35403708
http://dx.doi.org/10.1002/ijc.34024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320802/
https://www.ncbi.nlm.nih.gov/pubmed/35403708
http://dx.doi.org/10.1002/ijc.34024

Ejemplares similares